Leiomyosarcoma of the inferior vena cava as etiology of chronic abdominal pains - a case report.

Inferior vena cava leiomyosarcomas are rare tumors that account for less than 0.7% of all retroperitoneal leiomyosarcomas. They are more common in women and cause nonspecific chronic abdominal pain. In this report, we present the case of a 53-year-old female patient complaining of chronic nonspecific periumbilical abdominal pain with initial onset 8 months previously who was diagnosed with inferior vena cava leiomyosarcoma by computed tomography angiography. The patient was treated with complete resection of the tumor and reconstruction of the inferior vena cava with interposition of a Dacron prosthetic graft. The treatment considered the gold standard consists of complete surgical excision, because these tumors are resistant to chemotherapy and radiotherapy. The prognosis of these patients is closely related to early diagnosis. Therefore, it is very important that vascular and general surgeons know that this disease is a possible differential diagnosis of chronic abdominal pains.

Impact of COVID-19 on the surgical profile of vascular surgery patients at a tertiary hospital in Curitiba, Brazil.

Background: During the COVID-19 pandemic, healthcare services reduced the number of elective procedures performed. Vascular surgery patients are a group at risk of contracting severe forms of the infection, but are also susceptible to complications of their underlying diseases if they do not receive routine care. It is therefore necessary to understand the direct and indirect impacts and consequences of the pandemic on vascular patients. Objectives: To assess the impact of 1 year of the pandemic on a vascular surgery service and changes to the profile of surgeries during the same period. Methods: An analysis was conducted of the medical records of patients who underwent elective and emergency surgery from 2019 to 2021. A review of the literature was also conducted, using the search terms "vascular surgery", "COVID-19", and "amputations". Data were analyzed with Stata/SE v.14.1 (StataCorpLP, United States). Results: A total of 1,043 surgeries were identified during the study period, 51.6% conducted pre-pandemic and 48.4% performed during the pandemic. There was a reduction in the number of elective surgeries and an increase in the number of lower limb amputations and surgical debridements. Increases were also observed in the proportion of patients with peripheral arterial occlusive disease with advanced Rutherford classifications and in the number of cases of diabetic foot. Conclusions: The reduction in elective care and patients' reluctance to seek health services during the pandemic are the probable causes of increased severity of patient status, with greater need for lower limb amputation and surgical debridement and changes to the profile of the surgery performed at the service.

The effectiveness of aspirin for migraine prophylaxis: a systematic review.

CONTEXT AND OBJECTIVE:: Many researchers have suggested that aspirin prevents migraines. However, the evidence is unclear. The aim of this study was to analyze the available evidence on the effect of aspirin as a migraine prophylactic. DESIGN AND SETTING:: Systematic review, conducted at the Pontifícia Universidade Católica do Paraná, Brazil, and at the University of São Paulo, Brazil. METHODS:: We performed electronic searches in the databases of MEDLINE/PubMed, Embase, WEB OF SCIENCE, the World Health Organization, CENTRAL and OpenGrey, and we also searched manually for interventional studies published before April 2016 that compared the effects of aspirin with a control, in adults. Two authors independently extracted data on the publication, population recruited, intervention (aspirin dosage, follow-up and combined treatment) and main outcomes (frequency, severity and duration of migraine). We evaluated the quality of the studies using the Cochrane risk-of-bias tool. RESULTS:: Our search retrieved 1,098 references, of which 8 met the selection criteria for this systematic review. The total population was 28,326 participants (18-64 years old); most (96%) were men. The dosage varied from 50 to 650 mg/day across the studies. The risk of bias was generally low or unclear. The only outcome for which most of the studies included (6/8) reported a significant reduction was frequency of migraine, which was reduced at an aspirin dosage of at least 325 mg/day. CONCLUSION:: Aspirin can reduce the frequency of migraines. However, the optimal dosage is unclear.

The effectiveness of aspirin for migraine prophylaxis: a systematic review / Eficácia da aspirina na profilaxia da enxaqueca: uma revisão sistemática

ABSTRACT CONTEXT AND OBJECTIVE: Many researchers have suggested that aspirin prevents migraines. However, the evidence is unclear. The aim of this study was to analyze the available evidence on the effect of aspirin as a migraine prophylactic. DESIGN AND SETTING: Systematic review, conducted at the Pontifícia Universidade Católica do Paraná, Brazil, and at the University of São Paulo, Brazil. METHODS: We performed electronic searches in the databases of MEDLINE/PubMed, Embase, WEB OF SCIENCE, the World Health Organization, CENTRAL and OpenGrey, and we also searched manually for interventional studies published before April 2016 that compared the effects of aspirin with a control, in adults. Two authors independently extracted data on the publication, population recruited, intervention (aspirin dosage, follow-up and combined treatment) and main outcomes (frequency, severity and duration of migraine). We evaluated the quality of the studies using the Cochrane risk-of-bias tool. RESULTS: Our search retrieved 1,098 references, of which 8 met the selection criteria for this systematic review. The total population was 28,326 participants (18-64 years old); most (96%) were men. The dosage varied from 50 to 650 mg/day across the studies. The risk of bias was generally low or unclear. The only outcome for which most of the studies included (6/8) reported a significant reduction was frequency of migraine, which was reduced at an aspirin dosage of at least 325 mg/day. CONCLUSION: Aspirin can reduce the frequency of migraines. However, the optimal dosage is unclear.

RESUMO CONTEXTO E OBJETIVO: Muitos pesquisadores têm sugerido que a aspirina previne enxaquecas. No entanto, a evidência não é clara. O objetivo deste estudo foi analisar as evidências disponíveis para os efeitos da aspirina como um profilático da enxaqueca. DESENHO E LOCAL: Revisão sistemática, realizada na Pontifícia Universidade Católica do Paraná, Brasil, bem como na Universidade de São Paulo, Brasil. MÉTODOS: Foram realizadas buscas eletrônicas nas bases de dados MEDLINE/PubMed, Embase, WEB OF SCIENCE, Organização Mundial de Saúde, CENTRAL e OpenGrey. Nós buscamos manualmente estudos de intervenção publicados antes de abril de 2016, comparando efeitos da aspirina com um controle em adultos. Dois autores extraíram independentemente os dados de publicação, população recrutada, intervenção (dose de aspirina, acompanhamento e tratamento combinado) e os resultados principais (frequência, gravidade e duração da enxaqueca). Foi avaliada a qualidade dos estudos com a ferramenta da Cochrane para risco de viés. RESULTADOS: A nossa busca recuperou 1.098 referências, das quais 8 preencheram os critérios de seleção para esta revisão sistemática. A população total foi de 28,326 participantes (18-64 anos); a maioria (96%) de homens. A dosagem variou entre 50 a 650 mg/dia em todos os estudos. O risco de viés foi geralmente baixo ou pouco claro. O único desfecho para o qual a maioria dos estudos incluídos (6/8) relatou redução significativa foi a frequência de enxaqueca, que foi reduzida com uma dose de aspirina de pelo menos 325 mg/dia. CONCLUSÃO: A aspirina pode reduzir a frequência das enxaquecas; no entanto, a dosagem ideal não é clara.